Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
FORTNA Announces Strategic Global Partnerships with Packsize and Sitma
-
ACG Announces Results of Annual General Meeting of Shareholders
-
Qlik Introduces Enhanced Integrations with SAP, Databricks, and Snowflake to Drive Greater AI Value Creation
-
ECD Automotive Design Enters Into a Strategic Relationship with One Drivers Club for First Retail Launch, Bringing a Unique Design Center Experience to West Palm Beach
-
Orion Secures Major New Account in Turnkey LED Lighting Retrofit Projects for Leading Nationwide Building Products Distributor
-
Form 8.3 - Volex plc - Octopus Investments
-
Purple Biotech Announces $2.8 Million Registered Direct Offering of American Depositary Shares
-
Form 8.3 - Learning Technologies Group plc - Octopus Investments
-
ManTech Wins $269 Million Contract for Information Warfare Solutions
-
Palisade Bio Announces Preliminary Data from Phase 1 Clinical Study of PALI-2108 for the Treatment of Moderate-to-Severe Ulcerative Colitis Appears to be Safe and Well Tolerated in Treated Subjects
-
Sree Koneru, PhD Joins the Board of Directors of BioElectronics Corporation
-
21.co Announces Plans for New Operating Structure; 21Shares and 21.co Technologies to Become Separate Entities
-
NEO Battery Materials Announces Director Resignation and Updates to Upcoming Corporate Webinar
-
Alliance Witan PLC - Net Asset Value
-
Form 8.3 - Aviva plc
-
Sono Group N.V. to Present at NobleCon20 on December 4, 2024
-
Greenridge Exploration Announces Flow Through Financing
-
Form 8.3 - Direct Line Insurance Group plc
-
Form 8.3 - Loungers Plc
-
Seneca Polytechnic named as a Greater Toronto’s Top Employer for the 16th time
-
Know Rare Launches HealthStoryAI App for People Living with Rare Disease
-
Elevar Therapeutics and Relay Therapeutics Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors
-
Relay Therapeutics and Elevar Therapeutics Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors
-
Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants
-
OSS Announces Follow-On Order and Design Win from a Leading Defense Contractor in Asia for an Autonomous Maritime Application
-
PDS Biotech to Host Key Opinion Leader Event on December 17 at 12 p.m. ET
-
ManTech Wins $715 Million Marine Corps Warfighting Lab Contract
-
Opus Genetics to Host Virtual KOL Event on OPGx-LCA5 as a Treatment for LCA5-Associated Inherited Retinal Disease on December 11, 2024
-
Vortex Energy Completes High-Resolution UAV Magnetic Survey at the North Block of the Robinsons River Salt Project
-
Enphase Energy Unveils Busbar Power Control to Significantly Reduce Main Electrical Panel Upgrades
-
Unnatural Products Announces BridgeBio Exercises Option to License Macrocyclic Therapeutics for Development in Rare Diseases and Oncology
-
Arcutis Announces Promotions on Executive Management Team
-
New ScyllaDB Release Delivers Unprecedented Elasticity & Efficiency via “Tablets” Architecture
-
Satelytics Named to Inc.’s 2024 Best in Business List, For Accelerating Sustainability Goals Through AI-powered Geospatial Analytics
-
Volaris Group Acquires Orkis
-
RTI Appoints Three New Advisory Board Members to Address Growing Business in Commercial Markets
-
Beyond Oil Kicks Off Initial Sales and Pilots in the U.S. and Appoints Industry Veteran Jason Hatfield to Lead U.S. Sales
-
Excision BioTherapeutics Announces Oral Presentation at the 5th Genome Editing Therapeutics Summit
-
Rincell and Re:Build Manufacturing partner to deliver industry-leading battery packs powered by Rincell's ultra-high-capacity silicon-graphite lithium-ion batteries
-
Cerence AI Names Tony Rodriquez as Chief Financial Officer
-
Aspira Women’s Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award
-
Starton Therapeutics to Present at Biotech Showcase 2025
-
4Blanc Maéstro™ Named 2024 “Nailcare Tool Product of the Year” By Beauty Innovation
-
Electrify Expo Expands E-Bike Demo Experiences to Include Dealers and Bike Shops for 2025 Season
-
LifeVantage to Participate in the Water Tower Fireside Chat Series
-
Praxis Precision Medicines to Present at Upcoming December Investor Conferences
-
Village Super Market, Inc. Reports Results for the First Quarter Ended October 26, 2024
-
Global Uranium Engages Big Rock Exploration to Advance Wyoming Uranium Projects
-
PolarityBio Announces Interim Enrollment Achieved in SkinTE’s Phase III Pivotal Study
-
Majority of Newcomers Make Charitable Donations yet a Quarter Regret Immigrating


